ASTH financial statements and SEC filings
ASTH annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $3.18B | $78.53M | $22.49M | 10-K |
| 2024-12-31 | $2.03B | $89.35M | $43.15M | 10-K |
| 2023-12-31 | $1.39B | $84.61M | $60.72M | 10-K |
| 2022-12-31 | $1.14B | $104.27M | $45.17M | 10-K |
| 2021-12-31 | $773.91M | $98.18M | $68.92M | 10-K |
| 2020-12-31 | $687.18M | $80.50M | $37.69M | 10-K/A |
ASTH annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $2.22B | $1.66B | $793.30M | 10-Q |
| 2024-12-31 | $1.35B | $840.73M | $716.73M | 10-K |
| 2023-12-31 | $933.36M | $522.59M | $616.65M | 10-K |
| 2022-12-31 | $966.21M | $407.67M | $544.31M | 10-K |
| 2021-12-31 | $867.36M | $356.72M | $454.11M | 10-K/A |
| 2020-12-31 | $817.49M | $372.34M | $330.91M | 10-K |
ASTH annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $114.60M | -$10.11M | $569.35M | 10-K |
| 2024-12-31 | $52.20M | -$8.03M | $135.15M | 10-K |
| 2023-12-31 | $68.23M | -$28.53M | $3.42M | 10-K |
| 2022-12-31 | $82.13M | -$22.94M | -$20.09M | 10-K |
| 2021-12-31 | $70.33M | -$19.22M | -$47.75M | 10-K |
| 2020-12-31 | $46.16M | -$1.16M | -$51.70M | 10-K/A |